Aurora Cannabis Inc. (ACB) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Greetings, and welcome to Aurora Cannabis Incorporated Fiscal First Quarter 2026 Results Conference Call. All participants will be in a listen-only mode. A question and answer session will follow the formal presentation. The conference is being recorded today, Wednesday, August 6, 2025. I would now like to turn the conference over to your host, Kevin Nyland, Senior Director of Strategic Finance and Investor Relations. Please go ahead, sir. Hello, and thank you for joining us. With me are Miguel Martin, Executive Chairman and CEO, and Simona King, CFO. Earlier this morning, we filed our financials for the first quarter of the 2026 period, ending June 30th, 2025, and issued a news release containing these results. This news release, along with our financial statements and MD&A, are available on our IR website, as well as via CDAR Plus and EDGAR. Our discussion today gives a reminder that certain matters can constitute forward-looking statements that are subject to risks and uncertainties, relating to our future financial or business performance. Actual results could differ materially from those anticipated in those forward-looking statements. Risk factors that may affect actual results are detailed in our annual information form and other periodic call-ins and registration statements. These documents may similarly be accessed via CDAR Plus and EDGAR. Call-in prepared remarks by Miguel and Simona will conduct a question-answer session when we're covering analysts. With that, I'll turn the call over to Miguel. Please go ahead. Thanks, Kevin. We're executing our strategy within global medical cannabis and delivering strong results through sustained profitable growth. Our financial performance demonstrates Aurora's differentiated platform that is supported by a strong and ...